Genomics of circadian rhythms in health and disease.

Rijo-Ferreira F, Takahashi JS. · 2019

Read Genomics of circadian rhythms in health and disease. by Rijo-Ferreira F, Takahashi JS. (2019) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc6916512.txt.

Introduction

Rijo-Ferreira and Takahashi review the genomics of circadian rhythms. Their review appeared in Genome Medicine. Internal clocks run on a 24-hour cycle. They shape sleep, metabolism, and immune function. Clock genes switch other genes on and off in rhythm.

The authors trace how clock genes regulate sleep. They show how faulty gene expression harms metabolism. Recent work links the clock to the heart and nerves. It also links it to gut microbes, cancer, and aging. New studies show the clock shapes chromosome layout itself. These findings, they argue, could yield better timed treatments. They could also clarify the roots of many diseases.

Catalog record

CREATORRijo-Ferreira F, Takahashi JS.
YEAR2019
COLLECTIONPAPERS
FORMATTXT
FILE SIZE94 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC6916512

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Genomics of circadian rhythms in health and disease By Filipa Rijo-Ferreira, Joseph S Takahashi Published in: Genome Medicine DOI: 10.1186/s13073-019-0704-0 ABSTRACT Abstract Circadian clocks are endogenous oscillators that control 24-h physiological and behavioral processes. The central circadian clock exerts control over myriad aspects of mammalian physiology, including the regulation of sleep, metabolism, and the immune system. Here, we review advances in understanding the genetic regulation of sleep through the circadian system, as well as the impact of dysregulated gene expression on metabolic function. We also review recent studies that have begun to unravel the circadian clock’s role in controlling the cardiovascular and nervous systems, gut microbiota, cancer, and aging. Such circadian control of these systems relies, in part, on transcriptional regulation, with recent evidence for genome-wide regulation of the clock through circadian chromosome organization. These novel insights into the genomic regulation of human physiology provide opportunities for the discovery of improved treatment strategies and new understanding of the biological underpinnings of human disease. BACKGROUND Circadian rhythms are driven by an internal timing system regulated at the transcriptional level that gives rise to gene networks that oscillate with a 24-h cycle. Within these networks are clock genes that control rhythms in physiology and behavior. Interestingly, the circadian clock genes were among the first genes to be identified as controlling behavior. Following studies by Konopka and Benzer [1], who identified the first circadian mutant—period—in fruit flies, a forward-genetic behavioral screen was implemented in mice. Through this screen, the first circadian mutant mouse was identified [2], followed by the cloning of the first mammalian circadian gene, Clock [3]. Research into the mechanisms of mammalian circadian rhythms then exploded, with many additional genes added to the clock core loop [4–11] (Fig. 1). Since then, it has become clear that the circadian system plays an overarching role in regulating human physiology [46]. Recent studies have provided further lessons on how disruption of circadian rhythms is associated with sleep disorders [47, 48], cancer [49, 50], susceptibility to infections [51, 52], metabolic syndrome [53], Alzheimer’s disease [54], and aging [55]. There is also some indication that, in addition to controlling circadian gene expression, clock genes can influence other cellular functions in a non-circadian manner [56]. [Figure: Timeline of major findings in mammalian circadian clock research. 1920s: first long-term recordings of locomotor rhythms in rats (reviewed in [12]). 1960: Cold Spring Harbor Symposium on Biological Clocks. First observations that time of day determines susceptibility to endotoxins [13]. 1972: lesion studies show that the suprachiasmatic nucleus (SCN) of the hypothalamus regulates adrenal corticosterone and drinking behavior rhythms [14, 15]. Late 1970s and 1980s: first ENU screens for novel gene identification were performed in mammals [16]. 1984–1990: identification of the SCN as a master regulator through transplantation experiments [17, 18]. 1988: a naturally occurring circadian Tau mutation was identified in hamsters [19]. 1990s: first mammalian ENU screens for behavior, leading to the identification of the first mammalian clock gene, Clock [2]. 1995: circadian rhythms were shown to be cell-autonomous in mammals, being retained in isolated SCN neurons [20]. 1997: cloning of the Clock gene, which was shown to belong to the bHLH–PAS family of transcription factors. In the same year, the mammalian Per1 gene was also cloned, both providing entry points for identifying the mechanism of circadian rhythmicity in mammals [3, 8]. 1998–2000: Discovery of BMAL1/MOP3 as the partner of CLOCK [5, 11], repression by CRY [10] and the Per1/2-Cry1/2 feedback loop on CLOCK:BMAL1 [21]. First descriptions of circadian clocks in the periphery [22, 23]. The cloning of the hamster Tau mutant identified CK1ε as an important kinase regulating the core circadian clock [24]. 2000s: melanopsin was identified as the circadian photoreceptor in the retina [25–27]. 2001: first mutation in a clock gene associated with human disease [28]. 2002: first circadian transcriptomes revealed a significant subset of genes that have cyclic gene expression with a 24-h period [29–31]. 2004–2005: association of mutations in clock genes with impaired metabolism [32, 33]. 2011: peroxiredoxin cycles reported to be independent of transcription [34]. 2011–2012: detailed descriptions of genome-wide regulation by the clock [35–38]. 2012–2013: major advances in our understanding of the clock control of immunity [39–42]. Present day: a new layer in our understanding of genome-wide regulation by the clock through circadian chromosome organization is emerging [43–45]. ENU, N-ethyl-N-nitrosourea] This review focuses on the most recent advances in mammalian circadian rhythms research, highlighting novel techniques and explaining the importance and implications of these research findings for human disease, translational research, and medicine. We discuss a number of modern genomics approaches to the study of circadian rhythms, such as the evaluation of chromatin dynamics and gene regulation. Owing to the circadian functions that are common to these diseases, another factor that we highlight is the opportunity to intervene using the timed administration of drugs (chrono-pharmacology) or by targeting clock components. Indeed, as we discuss throughout this review, there may be great benefits to considering circadian timing in the treatment of metabolic disorders, cardiovascular disease, and cancer [53, 57, 58]. CURRENT VIEW OF THE MAMMALIAN MOLECULAR CLOCK The circadian clock in mammals is cell-autonomous and depends on transcriptional autoregulatory feedback loops (Fig. 2). Circadian rhythms are also tuned at the post-transcriptional [59] and post-translational levels [60], although gene transcription remains vital for making the clock ‘tick’. Genome-wide approaches (Additional file 1: Table S1) have found that rhythmic transcription is accompanied by rhythmic transcription factor binding and histone modifications in enhancer regions [61], as well as by circadian recruitment of RNA polymerase II (Pol II) to DNA [35, 36, 62]. An additional layer of regulation involves chromosome organization, with interactions of active and repressive chromosomal domains undergoing circadian oscillations [63–67]. [Figure: The circadian gene network and layers of genome-wide regulation in mammals. At the core of the network, the transcription factors CLOCK and BMAL1 activate the Per1, Per2, Cry1, and Cry2 genes (here we show Per2 and Cry1 as examples), whose protein products (PER and CRY) repress their own transcription. The PER and CRY proteins are post-translationally regulated by parallel E3 ubiquitin ligase pathways (FBXL3 and FBXL21 for CRY and β-TrCP for PER), with PER levels being also regulated by CK1. CLOCK and BMAL1 also regulate the expression of the Nr1d1/2 genes, which encode the nuclear receptors REV-ERBα/β, respectively. These nuclear receptors rhythmically repress the transcription of Bmal1 and Nfil3, two genes that are activated by retinoic acid-related orphan receptor-α/β (RORα/β). In turn, NFIL3 together with D-box binding protein (DBP), as well as CLOCK and BMAL1, regulate a rhythm in the REV-ERBα/β nuclear receptors. These three interlocked transcriptional feedback loops regulate the majority of cycling genes, leading to rhythms in various different physiological systems, from sleep to metabolism and aging (bottom of figure). Note that the E- and D-boxes and the RORE-binding regions are in cis upstream at the promoter; however, they are represented here as a stacked box for simplicity. Recent work has identified additional levels of regulation of circadian gene expression (outer layer of regulation in the figure), including rhythmic histone modifications, RNA polymerase II (Pol II) recruitment, circadian chromosomal conformation interactions and post-translational modifications (PTMs). Please refer to Table S1 for many of the studies that allowed the external regulatory layers to be

Read the complete text